NCT04529590View on ClinicalTrials.gov

Precise Treatment of Prediabetes and Stage 1 Hypertension

CompletedOBSERVATIONAL
Enrollment

2,004

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

September 30, 2023

Conditions
Diabetes
Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT04529590 - Precise Treatment of Prediabetes and Stage 1 Hypertension | Biotech Hunter | Biotech Hunter